These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35198408)

  • 1.
    Bringezu F; Simon S
    Toxicol Rep; 2022; 9():250-255. PubMed ID: 35198408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.
    Araki A; Muramatsu M; Matsushima T
    Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of short-chain alkyl N-nitrosamines using Aroclor 1254 or phenobarbital/beta-naphthoflavone-induced rat or hamster S9 - A comparative analysis.
    Dieckhoff J; Bringezu F; Simon S
    Toxicol Rep; 2024 Jun; 12():215-223. PubMed ID: 38322170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ames test study designs for nitrosamine mutagenicity testing: qualitative and quantitative analysis of key assay parameters.
    Thomas DN; Wills JW; Tracey H; Baldwin SJ; Burman M; Williams AN; Harte DSG; Buckley RA; Lynch AM
    Mutagenesis; 2024 Mar; 39(2):78-95. PubMed ID: 38112628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A; Kamigaito N; Sasaki T; Matsushima T
    Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
    Gatehouse DG; Paes DJ
    Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 50 Hz, 14 mT magnetic field is not mutagenic or co-mutagenic in bacterial mutation assays.
    Nakasono S; Ikehata M; Koana T; Saiki H
    Mutat Res; 2000 Nov; 471(1-2):127-34. PubMed ID: 11080668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures.
    Yim SH; Hee SS
    Mutat Res; 2001 May; 492(1-2):13-27. PubMed ID: 11377240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
    Negishi T; Hayatsu H
    Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenic assessment of olmesartan cilexetil by bacterial mutation assay.
    Kim JW; Ahn I; Ryu SH; Jeon HR; Lee BS; Kim KB
    Toxicol Res; 2013 Sep; 29(3):217-9. PubMed ID: 24386523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propyldazine is mutagenic in Salmonella typhimurium and Escherichia coli: distinct specificity for strains TA1537 and TA97.
    Glatt H; Oesch F
    Teratog Carcinog Mutagen; 1985; 5(5):339-45. PubMed ID: 2867616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are all bacterial strains required by OECD mutagenicity test guideline TG471 needed?
    Williams RV; DeMarini DM; Stankowski LF; Escobar PA; Zeiger E; Howe J; Elespuru R; Cross KP
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Dec; 848():503081. PubMed ID: 31708075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of organic solvents on the mutagenicity of N-nitrosodialkylamines in Salmonella.
    Mori Y; Yamazaki H; Toyoshi K; Emi Y; Uchida K; Tsutsumi M; Konishi Y
    Mutat Res; 1985 Apr; 142(4):153-8. PubMed ID: 3885018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic evaluation of trichlorfon using different assay methods with Salmonella typhimurium.
    Barrueco C; Herrera A; de la Peña E
    Mutagenesis; 1991 Jan; 6(1):71-6. PubMed ID: 2038275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate frequency magnetic fields do not have mutagenic, co-mutagenic or gene conversion potentials in microbial genotoxicity tests.
    Nakasono S; Ikehata M; Dateki M; Yoshie S; Shigemitsu T; Negishi T
    Mutat Res; 2008 Jan; 649(1-2):187-200. PubMed ID: 17997348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro mutagenicity of valepotriates.
    von der Hude W; Scheutwinkel-Reich M; Braun R; Dittmar W
    Arch Toxicol; 1985 Feb; 56(4):267-71. PubMed ID: 3994511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutagenicity test of halopredone acetate].
    Ohuchida A; Yoshida R; Morita K
    J Toxicol Sci; 1985 Aug; 10 Suppl 1():123-8. PubMed ID: 3906145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
    Rumruen K; Pool BL
    Mutat Res; 1984; 140(2-3):147-53. PubMed ID: 6379440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D; Wedd DJ
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.